The development of innovative Multiplexed Molecular Imaging technology targeting improved diagnostic imaging of Glioblastoma Multiforme [ 2012 - 2015 ]

Research Grant

Researchers: Prof Stephen Rose (Principal investigator) ,  A/Pr Paul Thomas ,  Dr Michael Fay ,  E/Pr Andrew Boyd ,  Prof Andrew Whittaker
View all 6 related researchers

Brief description Glioblastoma Multiforme (GBM) is extremely invasive and the most lethal of all primary brain tumours. To optimise treatment planning, we propose to develop novel Multiplexed Molecular Imaging (MMI) technology employing the latest PET-MRI hybrid imaging technology. Our strategy targets the development of new F19 MRI MI agents for measuring tumour infiltration that can be multiplexed with F18 PET hypoxia tracers. Our MI agents can also act as conjugative vehicles for drug delivery.

Funding Amount $AUD 403,599.97

Funding Scheme Project Grants

Notes Standard Project Grant